MARKET

ENLV

ENLV

Enlivex Ltd
NASDAQ
0.9000
-0.1500
-14.29%
After Hours: 0.9200 +0.02 +2.22% 19:40 03/30 EDT
OPEN
1.010
PREV CLOSE
1.050
HIGH
1.020
LOW
0.8743
VOLUME
379.35K
TURNOVER
--
52 WEEK HIGH
2.100
52 WEEK LOW
0.6600
MARKET CAP
213.64M
P/E (TTM)
-1.6502
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENLV last week (0323-0327)?
Weekly Report · 19h ago
Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets
TipRanks · 4d ago
Enlivex Posts $1.23 Billion Profit for 2025 on Treasury Asset Gains
TipRanks · 5d ago
Envilex Therapeutics GAAP EPS of $25.48
Seeking Alpha · 5d ago
Crypto Currents: NYSE tokenization tests SEC and CFTC’s new crypto line
TipRanks · 6d ago
Enlivex Secures $21 Million Convertible Debt, Expands RAIN Token Holdings and Launches $20 Million Buyback
TipRanks · 6d ago
Enlivex Wins FDA IND Clearance for Global Phase 2b Trial of Allocetra in Knee Osteoarthritis
TipRanks · 03/23 12:26
Enlivex Therapeutics announces FDA clearance of Allocetra new drug application
TipRanks · 03/23 12:21
More
About ENLV
Enlivex Ltd, formerly known as Enlivex Therapeutics Ltd, is an Israel-based clinical-stage macrophage reprogramming immunotherapy company developing Allocetra, an off-the-shelf cell therapy designed to restore macrophages to their homeostatic state. The Company focuses on diseases in which macrophages are pathologically reprogrammed, such as solid cancers, sepsis and COVID‑19, where non-homeostatic macrophages contribute significantly to disease severity. By re-establishing macrophage homeostasis, Allocetra has the potential to provide an immunotherapeutic mechanism of action for life-threatening indications defined as unmet medical needs, either as a stand‑alone therapy or in combination with other treatments.

Webull offers Enlivex Ltd stock information, including NASDAQ: ENLV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENLV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENLV stock methods without spending real money on the virtual paper trading platform.